Young persons with cancer are particularly under-served, not solely because of the unique psychosocial challenges they face, but also due to the tardy pace of improvements in survival. Little is known of the biology of cancer afflicting this age-group. Few are entered onto clinical trials. They do not comfortably fit into either paediatric or adult environments. They "fall through the gaps". The AYA Cancer Bill of Rights comprehensively addresses these deficits. The other side of the coin is revealed – not the expectations of an entrenched medical system, but those of unfortunate AYA with cancer. The Bill of Rights is ambitious – and so it should be. Unless the benchmark is set at a laudable level, government agencies and policy-makers are unlikely to take the first steps committing their AYA cancer sufferers not only the best chance of cure, but the very best quality of cure.